While overexpression of PRELP has been reported to have tumor suppressive activity in solid tumors characterized by a reduced invasion, anchorage-independent growth, metastasis formation and tumorgenicity [42], PRELP expression is involved in the pathobiology of chronic lymphocytic leukemia [43]. Here, PRELP is linked to B-cell chronic lymphocytic leukemia.